Patents by Inventor Laurence Briant-Longuet

Laurence Briant-Longuet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7482000
    Abstract: A mutant Fab fragment of the 13B8.2 anti-CD4 antibody that binds a CD4 molecule and includes a mutation of at least one residue in a position situated in the VH variable domain of the heavy chain and/or in a position situated in the V? variable domain of the light chain.
    Type: Grant
    Filed: January 5, 2005
    Date of Patent: January 27, 2009
    Assignee: Centre National de la Recherche Scientifique - CNRS
    Inventors: Christian Devaux, Cédric Bes, Laurence Briant-Longuet, Martine Cerutti, Gérard Devauchelle, Thierry Chardes, Claude Granier, Bernard Pau
  • Publication number: 20080312140
    Abstract: The present invention is directed to compositions and methods of preventing for treating a retroviral infection, more particularly an HIV (human immunodeficiency virus) infection, and even more particularly an HIV-1 infection. The compositions and methods involve molecules that mimic the active site of the human CD4 protein.
    Type: Application
    Filed: June 22, 2006
    Publication date: December 18, 2008
    Inventors: Chaim Gilon, Shira Cohen, Christian Devaux, Laurence Briant-Longuet, Martine Bardy
  • Publication number: 20050226874
    Abstract: A mutant Fab fragment of the 13B8.2 anti-CD4 antibody that binds a CD4 molecule and includes a mutation of at least one residue in a position situated in the VH variable domain of the heavy chain and/or in a position situated in the V? variable domain of the light chain.
    Type: Application
    Filed: January 5, 2005
    Publication date: October 13, 2005
    Applicant: Centre National de la Recherche Scientifique - CNRS, a corporation of France
    Inventors: Christian Devaux, Cedric Bes, Laurence Briant-Longuet, Martine Cerutti, Gerard Devauchelle, Thierry Chardes, Claude Granier, Bernard Pau
  • Publication number: 20030113322
    Abstract: An isolated CDR-derived polypeptide from monoclonal antibody 13B8.2, a pharmaceutical composition including a pharmaceutically acceptable carrier and at least a peptide, and a method for treating a subject suffering from an autoimmune disorder, including administering to the subject a therapeutically effective amount of a pharmaceutical composition, a method for treating a subject suffering from a transplant rejection including administering to the subject a therapeutically effective amount of a pharmaceutical composition, a method for treating a subject suffering from an HIV immunodeficiency disorder including administering to the subject a therapeutically effective amount of a pharmaceutical composition and a method for treating a subject suffering from a tumoral disorder including administering to the subject a therapeutically effective amount of a pharmaceutical composition.
    Type: Application
    Filed: December 18, 2002
    Publication date: June 19, 2003
    Inventors: Cedric Bes, Laurence Briant-Longuet, Martine Cerutti, Thierry Chardes, Gerard DeVauchelle, Christian DeVaux, Claude Granier, Claude Mawas, Daniel Olive, Bernard Pau